BridgeBio Pharma, Inc. (BBIO)
72.44
-0.06
(-0.08%)
USD |
NASDAQ |
Sep 11, 16:00
72.48
+0.04
(+0.06%)
After-Hours: 20:00
BridgeBio Pharma Total Return Level : 72.44 for Sept. 11, 2026
Total Return Level Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Return Level Data
| Date | Value |
|---|---|
| September 11, 2026 | 72.44 |
| September 10, 2026 | 72.50 |
| September 09, 2026 | 76.08 |
| September 08, 2026 | 74.76 |
| September 04, 2026 | 74.84 |
| September 03, 2026 | 75.41 |
| September 02, 2026 | 76.50 |
| September 01, 2026 | 76.57 |
| August 31, 2026 | 76.59 |
| August 28, 2026 | 76.60 |
| August 27, 2026 | 78.68 |
| August 26, 2026 | 79.37 |
| August 25, 2026 | 80.40 |
| August 24, 2026 | 81.07 |
| August 21, 2026 | 81.50 |
| August 20, 2026 | 82.94 |
| August 19, 2026 | 83.95 |
| August 18, 2026 | 82.98 |
| August 17, 2026 | 79.89 |
| August 14, 2026 | 79.86 |
| August 13, 2026 | 81.21 |
| August 12, 2026 | 83.84 |
| August 11, 2026 | 83.70 |
| August 10, 2026 | 84.67 |
| August 07, 2026 | 84.48 |
| Date | Value |
|---|---|
| August 06, 2026 | 82.80 |
| August 05, 2026 | 81.99 |
| August 04, 2026 | 82.07 |
| August 03, 2026 | 79.96 |
| July 31, 2026 | 80.09 |
| July 30, 2026 | 82.14 |
| July 29, 2026 | 83.54 |
| July 28, 2026 | 85.55 |
| July 27, 2026 | 84.12 |
| July 24, 2026 | 84.02 |
| July 23, 2026 | 82.93 |
| July 22, 2026 | 82.66 |
| July 21, 2026 | 82.45 |
| July 20, 2026 | 80.76 |
| July 17, 2026 | 81.38 |
| July 16, 2026 | 80.30 |
| July 15, 2026 | 82.66 |
| July 14, 2026 | 84.09 |
| July 13, 2026 | 83.08 |
| July 10, 2026 | 85.89 |
| July 09, 2026 | 90.17 |
| July 08, 2026 | 78.33 |
| July 07, 2026 | 77.91 |
| July 06, 2026 | 77.75 |
| July 02, 2026 | 77.19 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Return Level Benchmarks
| Alnylam Pharmaceuticals, Inc. | 248.68 |
| Ionis Pharmaceuticals, Inc. | 54.21 |
| Pfizer Inc. | 92.72 |
| Vertex Pharmaceuticals, Inc. | 515.44 |
| BioMarin Pharmaceutical, Inc. | 65.68 |